British Journal of Haematology: Vol 192, No 1

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Related Title

LATEST ISSUE
Volume 6, Issue 4
August 2025

Posts by @BritSocHaem

British Journal of Haematology

Journal list menu

Tools

Follow journal

British Journal of Haematology: Volume 192, Issue 1

Download PDFs

Issue Information

Issue Information

Images In Haematology

Promastigotes of Leishmania spp. developing in human bone marrow in vitro

A rare diagnosis of Hodgkin lymphoma in the absence of the expected rich inflammatory reaction

Commentary

JAGN1 mutations in severe congenital neutropenia

Antiviral prophylaxis for hepatitis B carriers affected by diffuse large B cell lymphoma: a matter of survival

‘CARMEN’: is less, more? Lessons from trials in human immunodeficiency virus-Burkitt lymphoma (HIV-BL)

Romiplostim in aplastic anaemia – another tool in the armamentarium

The Wider Perspective

Haematopoietic stem cell transplantation in Tanzania

Point: Is there a best duration of deep molecular response to achieve therapy-free remission in chronic myeloid leukaemia?

Counterpoint: There is a best duration of deep molecular response for treatment-free remission, but it is patient-specific, and that is the challenge

Molecular testing of chronic myeloid leukaemia in low resource areas

Reviews

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside

Epigenetic targeting in lymphoma

Haematological Malignancy - Clinical

Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study

Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study

Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma

Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based study

A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial

Haematological Malignancy - Biology

Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease

Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy

Platelets, Haemostasis and Thrimbosis

Computerised risk scores to guide recognition and diagnosis in patients with possible heparin-induced thrombocytopenia

Haemoglobinopathies

Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study

Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease

Liver complications of haemoglobin H disease in adults

Red Cells and Iron

Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron (57Fe)

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study

Correction(s) for this article

Erratum

Haematopoiesis

Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells

Correspondence

Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma

Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL)

Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosis

Online only

Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma

The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis

Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression

COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium

COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial

Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement

Intensive rituximab regimen in immune-mediated thrombotic thrombocytopenic purpura can circumvent unresponsiveness to standard rituximab treatment

The clinical picture of thrombotic microangiopathy in patients older than 60 years of age

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab

A novel KMT2A–USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia

Sign up for email alerts

Tools

More from this journal

NEW: COVID-19 and Haematology

Related Title

Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron (⁵⁷Fe)